Karyopharm Therapeutics Inc KPTI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:15 PM EDT
1.55quote price arrow up+0.07 (+5.07%)
Volume
762,269
52 week range
0.62 - 4.87
Loading...
  • Open1.45
  • Day High1.60
  • Day Low1.43
  • Prev Close1.48
  • 52 Week High4.87
  • 52 Week High Date04/17/23
  • 52 Week Low0.62
  • 52 Week Low Date12/11/23

Key Stats

  • Market Cap178.929M
  • Shares Out115.07M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change79.65

KEY STATS

  • Open1.45
  • Day High1.60
  • Day Low1.43
  • Prev Close1.48
  • 52 Week High4.87
  • 52 Week High Date04/17/23
  • 52 Week Low0.62
  • 52 Week Low Date12/11/23
  • Market Cap178.929M
  • Shares Out115.07M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change79.65

RATIOS/PROFITABILITY

  • EPS (TTM)-1.25
  • P/E (TTM)-1.24
  • Fwd P/E (NTM)-1.23
  • EBITDA (TTM)-129.01M
  • ROE (TTM)-891.04%
  • Revenue (TTM)146.033M
  • Gross Margin (TTM)96.62%
  • Net Margin (TTM)-97.99%
  • Debt To Equity (MRQ)-222.75%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Karyopharm Therapeutics Inc

 

Profile

MORE
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. It is developing and commercializing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead asset, XPOVIO (selinexor), is marketed in combination with...
Richard Paulson
President, Chief Executive Officer, Director
Michael Mason CPA
Chief Financial Officer, Executive Vice President, Treasurer
Sohanya Cheng
Executive Vice President, Chief Commercial Officer
Stuart Poulton
Executive Vice President, Chief Development Officer
Address
85 Wells Ave
Newton Center, MA
02459-3298
United States

Top Peers

SYMBOLLASTCHG%CHG
STRO
Sutro Biopharma Inc
5.92+0.99+19.98%
FGEN
FibroGen Inc
2.41-0.17-6.59%
AGEN
Agenus Inc
0.5663+0.0099+1.7793%
SGMO
Sangamo Therapeutics Inc
0.6407+0.016+2.5612%
HBIO
Harvard Bioscience Inc
4.24+0.04+0.83%